I'm sure IPIX management will be doing whatever they can to ensure the upfront payment on the pending deal is large enough to alleviate all financing concerns. We cannot keep getting hammered once we are no longer depending on our stock price for funding. It will all be up to the trials at that point.
It sure will be a treat once NR gives up and IPIX no longer has to pour 10+ million shares per year onto the OTC to stay funded. They never needed to get shareholders to sell. They only needed to keep new buyers from pulling the trigger while IPIX flooded the market for funding.
(0)
(3)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links